Preparation of Luciferin for
In Vitro Bioluminescent Assays
Materials
• D-Luciferin Firefly, potassium salt, 1.0 g /vial
(Caliper Life Sciences Part Number #119222)
• Sterile water
• Complete media
Procedure
1. Prepare a 200X Luciferin stock solution (30 mg/ml) in sterile water. Mix gently by inversion until Luciferin is completely dissolved. Use immediately, or aliquot and freeze at -20 °C for future use.
Note: One can either reconstitute the entire 1.0 g of D- Luciferin in 33.3 mL of sterile water to make the 30 mg/mL (200x) stock solution, or reconstitute the quantity of D-Luciferin necessary for an individual experiment.
2. Prepare a 150 μg/mL working solution of D-Luciferin in pre-warmed tissue culture medium.
Quick thaw 200X stock solution of Luciferin and dilute 1:200 in complete media (150 μg/mL final).
3. Aspirate media from cultured cells.
4. Add 1x Luciferin solution to cells just prior to imaging.
Note: Incubating the cells for a short time at 37 °C before imaging can increase the signal.
Preparation of Luciferin for
In Vivo Bioluminescent Assays
Materials
• D-Luciferin, Firefly, potassium salt, 1.0 g/vial
(Caliper Life Sciences Part Number #119222)
• DPBS, w/o Mg2+ and Ca2+
• Syringe filter, 0.2 um
Procedure
1. Prepare a fresh stock solution of Luciferin at 15mg/mL in DPBS. Filter sterilize through a 0.2 um filter.
2. Inject 10 μL/g of body weight. Each mouse should receive 150 mg Luciferin/kg body weight. (e.g. For a 10 g mouse, inject 100 μL to deliver 1.5 mg of Luciferin.)
3. Inject the Luciferin intra-peritoneally (i.p.) 10-15 minutes before imaging*.
* A Luciferin kinetic study should be performed for each animal model to determine peak signal time.
近日,大众集团旗下的软件公司CARIAD中国宣布,与中国顶尖的智能手机制造商vivo共同创建“手车互融联合创新实验室”(英文名:MobilexMobilityFusionJointInnovative......
近日,中国科学院大连化学物理研究所生物技术研究部生物分子高效分离与表征研究组研究员赵群、张丽华等,与中国科学院精密测量科学技术创新研究院副研究员龚洲合作,提出了利用原位化学交联-质谱技术(invivo......
万物蓬勃的7月里迎来了2022年ANTOP奖的申报和评审工作。由岛津企业管理(中国)有限公司申报的“3CoinONE全新体验气袋进样器”ANTOP奖进入专家评审阶段。奖项名称:3CoinONE全新体验......
青岛青源峰达太赫兹科技有限公司研发团队在国际顶级期刊《TrendsinBiotechnology》(译名:《生物技术趋势》)在线发表题为“THzmedicalimaging:frominvitroto......
蛋白质作为构成人体组织器官的支架和主要物质,在人体生命活动中起着重要作用。蛋白质的相互作用能产生许多效应,如形成特异底物作用通道、生成新的结合位点、失活、作用底物专一性和动力学变化等,细胞的代谢、信号......
2021年9月9日,无锡臻和生物科技有限公司(以下简称“臻和科技”)与美国VyantBio公司签署TissueofOrigin®(以下简称“TOO®”)全球权益和ZL转让协议,全资收购这款唯一获FDA......
2021年7月20日,JournalofCellularPhysiology及JournalofCellularBiochemistry同时撤回了中国学者49篇文章。从2019年开始,Journalo......
安进宣布,美国FDA授予其在研firstinclass单抗bemarituzumab突破性疗法认定,与改良FOLFOX6化疗方案(亚叶酸钙、氟尿嘧啶和奥沙利铂)联用,一线治疗FGFR2b过表达和HER......
2007年,中国科学院金属研究所研究员张志东在英国《哲学杂志》(PhilosophicalMagazine)上发表论文,提出两个猜想,并在猜想基础上推定出三维伊辛模型的精确解。被《哲学杂志》审稿人评价......
磷酸甘油酸突变酶1(PGAM1)通过其代谢活性以及与其他蛋白质(例如α平滑肌肌动蛋白(ACTA2))的相互作用,在癌症代谢和肿瘤进展中起关键作用。变构调节被认为是发现针对PGAM1的高选择性和有效抑制......